Literature DB >> 35544192

Mucormycosis: time to address this deadly fungal infection.

Neil Stone1, Nitin Gupta2, Ilan Schwartz3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 35544192     DOI： 10.1016/S2666-5247(21)00148-8

Source DB:  PubMed          Journal:  Lancet Microbe        ISSN： 2666-5247


× No keyword cloud information.
  10 in total

1.  Data mining of transcriptional biomarkers at different cotton fiber developmental stages.

Authors:  Uzma Khatoon; Priti Prasad; Rishi Kumar Verma; Samir V Sawant; Sumit K Bag
Journal:  Funct Integr Genomics       Date:  2022-07-05       Impact factor: 3.674

2.  Deoxycholate amphotericin for management of mucormycosis: a retrospective cohort study from South India.

Authors:  Nitin Gupta; Sourabh Srinivas; Anagha Harikumar; K Devaraja; Vishnu Teja Nallapati; Kavitha Saravu
Journal:  Infez Med       Date:  2022-09-01

Review 3.  Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives.

Authors:  Yasasve Madhavan; Kadambari Vijay Sai; Dilip Kumar Shanmugam; Aashabharathi Manimaran; Karthigadevi Guruviah; Yugal Kishore Mohanta; Divyambika Catakapatri Venugopal; Tapan Kumar Mohanta; Nanaocha Sharma; Saravanan Muthupandian
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

4.  Exenterate or Not: A Simple Proposed Management Algorithm for Mucormycosis During the Era of COVID-19 in a Tertiary Eye Care Center in Egypt.

Authors:  Reham Refaat Shabana; Mohamed Ashraf Eldesouky; Hazem A Elbedewy
Journal:  Clin Ophthalmol       Date:  2022-06-11

5.  In-hospital prevalence of mucormycosis among coronavirus disease 2019 (COVID-19) patients and COVID-19 in mucormycosis: a systematic review and meta-analysis.

Authors:  Akansha Sinha; Sonu Menachem Maimonides Bhaskar
Journal:  Int Forum Allergy Rhinol       Date:  2021-10-11       Impact factor: 5.426

Review 6.  Molecular Mapping of Antifungal Mechanisms Accessing Biomaterials and New Agents to Target Oral Candidiasis.

Authors:  Valentina Anuța; Marina-Theodora Talianu; Cristina-Elena Dinu-Pîrvu; Mihaela Violeta Ghica; Răzvan Mihai Prisada; Mădălina Georgiana Albu Kaya; Lăcrămioara Popa
Journal:  Int J Mol Sci       Date:  2022-07-07       Impact factor: 6.208

7.  Babesia microti-induced fulminant sepsis in an immunocompromised host: A case report and the case-specific literature review.

Authors:  Harry A Conte; Michael C Biondi; Sok-Ja Janket; Leland K Ackerson; Eleftherios P Diamandis
Journal:  Open Life Sci       Date:  2022-09-14       Impact factor: 1.311

8.  Investigation of an acute surge of COVID-19 associated mucormycosis (CAM) cases reported to a tertiary health care institution in Bihar, India.

Authors:  Chandra Mani Singh; Bijaya Nanda Naik; Sanjay Pandey; Prashant Kumar Singh; U R Rajath Rao; Prathyusha Kokkayil; Kranti Bhavana; Prabhat Kumar Singh
Journal:  J Family Med Prim Care       Date:  2022-06-30

Review 9.  COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic.

Authors:  Pankaj Chandley; Priyanka Subba; Soma Rohatgi
Journal:  Vaccines (Basel)       Date:  2022-08-06

10.  Changing Trend of Risk Factors of Mucormycosis Including Diabetes, Acidosis, and Serum Iron in the Second Wave of COVID-19.

Authors:  Prakrut Paidisetty; Vaishali Nagose; Vikrant Vaze; Neha Mahajan; Shivanand Rathod
Journal:  Indian J Microbiol       Date:  2022-09-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.